FEATURED SLIDESHOW
Who Is The Worst CEO?Mad Money needed new inductees for its
Wall of Shame, so we asked viewers for
nominations.
RECENT POSTS
- Time to Sell Eaton?
- Lightning Round: Unitedhealth, Wendy's and More
- Lightning Round OT: Yamana Gold, 3Com and More
- Cramer’s Christmas List: A Coffeemaker, Washing Machine and…
- Cramer’s Christmas List: TJX & Williams-Sonoma
- Cramer: Dubai Debt Can’t Sink These 6 Dividend Stocks
- Cramer: 3 Trades on Banks, Steel
- 4 Enemies of Bull Markets
- Experiencing Technical Difficulty?
- The Importance of Good Breadth
Text Size 
Don’t invest like George Soros, invest better than George Soros, Cramer said tonight.
Even a billionaire like Soros, the man who broke the British pound, will have some poor picks in his portfolio. So Cramer wants only the best. That’s why he’s leaving stocks like Bon Ton [BONT
Loading...
()
] and Qualcomm [QCOM
Loading...
()
] behind for a gem like Gen-Probe [GPRO
Loading...
()
].
Gen-Probe is a diagnostics company in an industry that Cramer said is on a tear. It makes tests for sexually transmitted diseases and pneumonia. GPRO has two new products to boot: one for West Nile and the other for HIV, Hepatitis B and Hep C. There are tests on deck for prostate cancer and HPV as well. Cramer likes the company so much – it’s “instant growth” – he thinks Abbot Labs should buy it to boost its own ailing diagnostics division.
Gen-Probe enjoys a 40% market share since it’s one of only two diagnostics firms approved to screen donated blood, thanks to big government regulation. The company also has alliances with GE [GE
Loading...
()
], parent company of CNBC, 3M [MMM
Loading...
()
] and Millipore [MIL
Loading...
()
] to extend GPRO tests into new areas.
Gen-Probe is a pastiche of different diagnostic tests for different diseases all in one stock. Good for Soros that he owns some, Cramer said.
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes